Stock Track | Harrow Health Soars 5.06% Intraday on Multiple Positive Analyst Ratings

Stock Track05-14

Harrow Health Inc's stock surged 5.06% during intraday trading on Wednesday, reflecting strong investor sentiment following a series of positive analyst actions.

The healthcare company received favorable attention from multiple analysts, with Lake Street maintaining a Buy rating and setting a price target of $60.00. Additionally, BTIG maintained its price target of $63.00 per share for Harrow Health, while Cantor Fitzgerald continued to rate the stock as Overweight.

These analyst endorsements suggest confidence in the company's prospects and may have contributed to the stock's significant upward movement during the trading session.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment